Fda 预测与赔率· 147 个市场
All
Will the FDA approve any COVID-19 vaccination for children under 12 by November 1?
$127k 交易量
$0 流动性
已结束
$127k 交易量$0 流动性已结束

All
Will any of the COVID vaccines be granted full FDA approval by September 1?
$140k 交易量
$0 流动性
已结束
$140k 交易量$0 流动性已结束

All
Will Johnson and Johnson's COVID-19 vaccine receive FDA approval or Emergency Use Authorization (EUA) by March 15, 2021?
$7k 交易量
$0 流动性
已结束
$7k 交易量$0 流动性已结束

All
Will Pfizer's COVID-19 vaccine be the first to receive FDA approval or Emergency Use Authorization (EUA)?
$152k 交易量
$0 流动性
已结束
$152k 交易量$0 流动性已结束

All
Will AstraZeneca's COVID-19 vaccine receive FDA approval or Emergency Use Authorization (EUA) by May 1, 2021?
$29k 交易量
$0 流动性
已结束
$29k 交易量$0 流动性已结束
All
Will the FDA approve any COVID-19 vaccination for children under 12 by October 15?
$129k 交易量
$0 流动性
已结束
$129k 交易量$0 流动性已结束

All
Will any of the COVID vaccines be granted full FDA approval by December 1?
$7k 交易量
$0 流动性
已结束
$7k 交易量$0 流动性已结束

All
Will the FDA give emergency use authorization or otherwise approve Paxlovid before 2022?
$147k 交易量
$0 流动性
已结束
$147k 交易量$0 流动性已结束
All
Will the FDA give emergency use authorization or otherwise approve Molnupiravir before 2022?
$16k 交易量
$0 流动性
已结束
$16k 交易量$0 流动性已结束

FDA approves Telix Pharmaceuticals’ TLX250-CDx for kidney cancer imaging?
$3k 交易量
$0 流动性
12
已结束
$3k 交易量$0 流动性12已结束
No

FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?
$15k 交易量
$0 流动性
12
已结束
$15k 交易量$0 流动性12已结束
Yes

FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?
$3k 交易量
$0 流动性
12
已结束
$3k 交易量$0 流动性12已结束
Yes
